NCBiotech Eyes Center to Capitalize on State's Personalized Medicine Culture | GenomeWeb

NEW YORK (GenomeWeb News) – The North Carolina Biotechnology Center sees the state as a potential hub for personalized medicine research and business, and has provided $100,000 for a project to begin exploring the possibility of creating a center that would focus on commercializing technologies to individualize medical diagnosis and treatment of each patient.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.